CXCR2 and neoplasm: To further elucidate the involvement of pivotal regulators CXCL2 in Fn-enhanced tumor growth and macrophage M2 polarization, we used a selective inhibitor SB225002 for CXCR2 (the receptor for chemokines CXCL2).